Company profilePharmaceutical#434 of 1,318 in Pakistan✓ No DRAP alerts

Cell Health Sciences,

Pharmaceutical company · 37 brands · 27 molecules

37 registered products 30 pharmaceutical brands 27 distinct molecules 0 DRAP alerts

Company overview

37
registered products
30
pharmaceutical brands
27
distinct molecules
0
therapeutic classes
0
DRAP alerts

Cell Health Sciences, is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 37 product registrations across 27 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Cell

21 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

21
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202621

Top molecules by brand count

Risperidone4 brands
Quetiapine4 brands
Cefixime3 brands
Azithromycin3 brands
Olanzapine2 brands
Ceftriaxone2 brands
Levofloxacin2 brands
Anastrozole2 brands

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official40 products · Rs 103.41 – Rs 12,635.59
Median across source: Rs 507.81

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

HIGH - Q INTERNATIONAL11 shared molecules
BIO LABS (PVT) LTD.11 shared molecules
IRZA PHARMA (PVT) LTD.11 shared molecules
EPHARM LABORATORIES10 shared molecules
PANACEA PHARMACEUTICALS9 shared molecules
NAVEGAL LABORATORIES9 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

HIGH - Q INTERNATIONAL holds 129 molecules not in this portfolio
000 I.UAcetyl L-CarnitineAmikacinAmlodipineAprepitantArachis Oil
BIO LABS (PVT) LTD. holds 129 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
IRZA PHARMA (PVT) LTD. holds 108 molecules not in this portfolio
AcetazolamideAcyclovirAdrenalineAlbendazoleAlbuterolAmikacin

Get the full profile for Cell

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.